Why Widecells?
21st June 2018
What’s more important than your health and that of your family? At WideCells we are leading a transformation in stem cell services and stem cell treatment to give you new
What’s more important than your health and that of your family? At WideCells we are leading a transformation in stem cell services and stem cell treatment to give you new
It’s estimated that 1 in 3 of us will need a stem cell transplant in our lifetime. What are stem cells? Stem cells are essential for the normal health and functioning
Congratulations! No doubt you’re glowing in your pregnancy. With advice and tips coming from all directions, naturally, as part of your journey you will be wondering how best to protect
WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that following the Group’s recent placing, Align
Widecells Group’s João Andrade & David Bridgland discuss why their shares were suspended, the placing & what the funds will be used for, being back in a stable position, operations, and key developments investors should look out for in this exclusive interview with DirectorsTalk
Teeth are an “excellent” source of stem cells which can be used in dentistry and regenerative medicine, according to new research published in the British Dental Journal. Scientists have confirmed
Widecells Group Plc (LON:WDC) CEO João Andrade & CFO David Bridgland talk to DirectorsTalk about the lifting of a trading suspension. João explains why the shares were suspended, if anything
Millions of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers revealed a breakthrough treatment that cuts out the need for
WideCells Group PLC (LON:WDC) the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, provides the following update on its financial position. As
WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, announced today its audited preliminary results for the period ended
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
